Dexamethasone modulates osteogenesis and adipogenesis with regulation of osterix expression in rat calvaria-derived cells

Journal of Cellular Physiology

Volumn 226, Issue 3, 2011, Pages 739-748

  Mikami, Yoshikazu ^a   Lee, Mio ^a   Irie, Seiko ^a   Honda, Masaki J ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; DEXAMETHASONE; TRANSCRIPTION FACTOR OSTERIX;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL DIFFERENTIATION; CELL ISOLATION; DRUG MECHANISM; ENZYME ACTIVITY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL LINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; LIPIDS; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; RATS; RNA, MESSENGER; SKULL; TIME FACTORS; TRANSCRIPTION FACTORS;

RATTUS;

EID: 78650634664     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22392     Document Type: Article

References (40)

1. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM, Nanes MS. 1996. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137: 3401-3407.
2. Canalis E, Economides AN, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235.
3. Centrella M, Rosen V, Wozney JM, Casinghino SR, McCarthy TL. 1997. Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J Cell Biochem 67: 528-540.
4. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY. 2009. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15: 682-689.
5. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
6. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
7. Ducy P, Schinke T, Karsenty G. 2000. The osteoblast: A sophisticated fibroblast under central surveillance. Science 289: 1501-1504.
8. Gimble JM, Robinson CE, Wu X, Kelly KA. 1996. The function of adipocytes in the bone marrow stroma: An update. Bone 19: 421-428.
9. Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, Wozney J. 1998. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 43: 356-364.
10. Ishida Y, Heersche JN. 1998. Glucocorticoid-induced osteoporosis: Both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 13: 1822-1826.
11. Ito S, Suzuki N, Kato S, Takahashi T, Takagi M. 2007. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40: 84-92.
12. Kato S, Kawabata N, Suzuki N, Ohmura M, Takagi M. 2009. Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line, ROB-C26, into mature osteoblasts and adipocytes. Life Sci 84: 302-310.
13. Kim IS, Song YM, Cho TH, Park YD, Lee KB, Noh I, Weber F, Hwang SJ. 2008. In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation. Dev Growth Differ 50: 553-564.
14. Kurokouchi K, Kambe F, Kikumori T, Sakai T, Sarkar D, Ishiguro N, Iwata H, Seo H. 2000. Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 15: 1707-1715.
15. Leboy PS, Beresford JN, Devlin C, Owen ME. 1991. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 146: 370-378.
16. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. 2003. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309: 689-694.
17. Li X, Jin L, Cui Q, Wang GJ, Balian G. 2005. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16: 101-108.
18. Lian JB, Shalhoub V, Aslam F, Frenkel B, Green J, Hamrah M, Stein GS, Stein JL. 1997. Species-specific glucocorticoid and 1, 25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 138: 2117-2127.
19. Lu X, Gilbert L, He X, Rubin J, Nanes MS. 2006. Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem 281: 6297-6306.
20. Luppen CA, Leclerc N, Noh T, Barski A, Khokhar A, Boskey AL, Smith E, Frenkel B. 2003a. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 278: 44995-45003.
21. Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B. 2003b. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18: 1186-1197.
22. Mikami Y, Omoteyama K, Kato S, Takagi M. 2007. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells. Biochem Biophys Res Commun 362: 368-373.
23. Mikami Y, Takahashi T, Kato S, Takagi M. 2008. Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26. Cell Biol Int 32: 239-246.
24. Mikami Y, Asano M, Honda MJ, Takagi M. 2010. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol 223: 123-133.
25. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
26. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T. 2002. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31: 303-312.
27. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ. 1981. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108: 213-219.
28. Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ. 1983. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 43: 4308-4314.
29. Pereira RC, Delany AM, Canalis E. 2002. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: Correlation with CCAAT-enhancer binding protein expression. Bone 30: 685-691.
30. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
31. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. 1994. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161: 218-228.
32. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. 2004. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145: 401-406.
33. Shi XM, Blair HC, Yang X, McDonald JM, Cao X. 2000. Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation. J Cell Biochem 76: 518-527.
34. Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B. 2000. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J Biol Chem 275: 19992-20001.
35. Smith E, Coetzee GA, Frenkel B. 2002. Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J Biol Chem 277: 18191-18197.
36. Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM, Li XJ. 1998. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 13: 1483-1490.
37. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528-1534.
38. Yamaguchi A, Kahn AJ. 1991. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49: 221-225.
39. Yamaguchi A, Komori T, Suda T. 2000. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393-411.
40. Yutaka A. 1998. TFSEARCH: Searching Transcription Factor Binding Sites. .